Olivier Féron

Molecular Biology · 2008–2017

A researcher in the Science corpus: 6 papers; trusts 3 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom Olivier Féron trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Peter Carmeliet

Who trusts Olivier Féron overall

  1. Pranali P. Deshpande
  2. G. Brooks
  3. P. Vaupel
  4. F. Danhier

Papers from Olivier Féron's perspective

Ordered by how strongly the researchers Olivier Féron trusts endorse each paper. Same corpus, a different order for every researcher.

  1. High interstitial fluid pressure — an obstacle in cancer therapy (Nature Reviews. Cancer)
  2. Mechanisms of angiogenesis and arteriogenesis (Nature Medicine)
  3. Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
  4. The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism* (Journal of Biological Chemistry)
  5. Causes and consequences of tumour acidity and implications for treatment. (Molecular medicine today)
  6. Nanoparticles in cancer therapy and diagnosis. (Advanced Drug Delivery Reviews)
  7. The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond (Pflügers Archiv)
  8. Exploiting tumour hypoxia in cancer treatment (Nature Reviews. Cancer)
  9. Paclitaxel and its formulations. (International journal of pharmaceutics)
  10. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. (Journal of Controlled Release)

Their papers